Brief: Alkermes To Present Data On Nemvaleukin Alfa At The American Society Of Clinical Oncology Gastrointestinal Cancers Symposium
18/01/2022 12:07
Jan 18 (Reuters) - Alkermes Plc ALKS.O :
* ALKERMES TO PRESENT DATA ON NEMVALEUKIN ALFA AT THE
AMERICAN
SOCIETY OF CLINICAL ONCOLOGY GASTROINTESTINAL CANCERS SYMPOSIUM
Source text for Eikon: ID:nPreLSdKsa
Further company coverage: ALKS.O
Recent news on Alkermes
See all newsBrief: Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study Of Alixorexton In Adults With Narcolepsy Type 2 At Sleep 2026
Brief: Alkermes Announces Positive Topline Results From Revitalyz Phase 3 Study Evaluating Lumryz
Brief: Alkermes Announces Effectiveness Of Mural Oncology Form 10 Registration Statement
Alkermes Plc reports results for the quarter ended in September - Earnings Summary
Brief: Alkermes Q3 Net Income USD 47.8 Million